MiniMed Group short interest was 47.64% of the float on September 15th, according to new data we received from Benzinga. Short interest totaled 13,594,922 shares, which was an increase of 68.66% from August 31st.
It is estimated that it would take 4.85 days for short sellers to buy back their shares, with current trading volumes.
MiniMed Group Hedge Fund Activity
We have seen 71 institutional investors add shares of MiniMed Group stock to their portfolio, and 26 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 2,851,539 shares (+inf%) to their portfolio in Q1 2026, for an estimated $42,544,961
- ALYESKA INVESTMENT GROUP, L.P. removed 2,000,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $29,900,000
- BLACKROCK, INC. added 1,970,314 shares (+7527.5%) to their portfolio in Q2 2026, for an estimated $29,456,194
- NORGES BANK added 1,961,002 shares (+inf%) to their portfolio in Q2 2026, for an estimated $29,316,979
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,505,778 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $22,511,381
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,456,278 shares (+21.2%) to their portfolio in Q2 2026, for an estimated $21,771,356
- EXODUSPOINT CAPITAL MANAGEMENT, LP added 1,437,067 shares (+inf%) to their portfolio in Q2 2026, for an estimated $21,484,151
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MiniMed Group Analyst Ratings
Wall Street analysts have issued reports on $MMED in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 03/31/2026
To track analyst ratings and price targets for MiniMed Group, check out Quiver Quantitative's $MMED forecast page.
MiniMed Group Price Targets
Multiple analysts have issued price targets for $MMED recently. We have seen 10 analysts offer price targets for $MMED in the last 6 months, with a median target of $20.5.
Here are some recent targets:
- Larry Biegelsen from Wells Fargo set a target price of $22.0 on 06/04/2026
- Travis Steed from B of A Securities set a target price of $20.0 on 05/18/2026
- Bruce Jackson from Benchmark set a target price of $20.0 on 05/12/2026
- Matt Miksic from Barclays set a target price of $26.0 on 04/01/2026
- Marie Thibault from BTIG set a target price of $25.0 on 03/31/2026
- Anthony Petrone from Mizuho set a target price of $21.0 on 03/31/2026
- Kallum Titchmarsh from Morgan Stanley set a target price of $19.0 on 03/31/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
